Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression

Stem cell transplantation is a possible therapeutic option to repair ischemic damage to the heart. However, it is faced with a number of challenges including the survival of the transplanted cells in the ischemic region. The present study was designed to use stem cells preconditioned with trimetazid...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Wisel, Sheik, Khan, Mahmood, Kuppusamy, M. Lakshmi, Mohan, I. Krishna, Chacko, Simi M., Rivera, Brian K., Sun, Benjamin C., Hideg, Kálmán, Kuppusamy, Periannan
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Pharmacology and Experimental Therapeutics 2009
Θέματα:
Cardiovascular
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2672865/
https://ncbi.nlm.nih.gov/pubmed/19218529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.109.150839
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια